Michael Schmitt

11.9k citations

273 papers · 7.1k indexed · 1 hit paper · h-index 43

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Oncology top 0.5%
- CAR-T cell therapy research

Papers in

Immunology 118
- Immunotherapy and Immune Responses 73
- Immune Cell Function and Interaction 46
- T-cell and B-cell Immunology 22
Hematology 60
- Hematopoietic Stem Cell Transplantation 30

Co-authors: Anita Schmitt Jochen Greiner Lawrence A. Loeb Hartmut Döhner Carsten Müller‐Tidow Maria‐Luisa Schubert Peter Dreger Jesse J. Salk
Journals: Blood (42 papers)International Journal of Cancer (11 papers)International Journal of Oncology (9 papers)Frontiers in Immunology (9 papers)Cancer Immunology Immunotherapy (7 papers)
Partner nations: Germany United States China

In The Last Decade

Michael Schmitt

265 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy 2020 · 340 citations

Peers

Countries citing papers authored by Michael Schmitt

Since Specialization

Citations

This map shows the geographic impact of Michael Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schmitt more than expected).

Fields of papers citing papers by Michael Schmitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schmitt. The network helps show where Michael Schmitt may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Schmitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Schmitt Line = papers co-authored together Michael Schmitt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo models Blood ·Berit J. Brinkmann, Alessia Floerchinger, Christina Schniederjohann, Tobias Roider, Mariana Coelho, Norman Mack, Peter‐Martin Bruch, Nora Liebers, Sarah Dötsch, Dirk H. Busch, Michael Schmitt, Frank Neumann, Philipp M. Roessner, Martina Seiffert, Sascha Dietrich	2024	7
2	Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study Arthritis Research & Therapy ·Maren Claus, Merle Freitag, Meike Ewald, Lea Rodon, Franca Sophie Deicher, Carsten Watzl, Philipp Kolb, Hanns‐Martin Lorenz, Michael Schmitt, Wolfgang Merkt	2024	7
3	Structurally Optimized, IL-2-Armored CLL1 CAR-NK Cells Are Highly Potent Effectors Against AML without Hpsc Toxicity Blood ·David Sedloev, Qian Chen, Julia M. Unglaub, Anita Schmitt, Carsten Müller‐Tidow, Michael Schmitt, Tim Sauer	2024	3
4	PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity Journal for ImmunoTherapy of Cancer ·Emmanuelle Moraes Ribeiro, Kathy-Ann Secker, Ana-Maria Nitulescu, Rebekka Schairer, Hildegard Keppeler, Anton Wesle, Hannes Schmid, Anita Schmitt, Brigitte Neuber, Daniela Chmiest, Silvia Podavini, Melanie Märklin, Boris Klimovich, Michael Schmitt, Fulya Korkmaz, Claudia Lengerke, Corina Schneidawind, Dominik Schneidawind	2024	7
5	Incorporating microglia‐like cells in human induced pluripotent stem cell‐derived retinal organoids Journal of Cellular and Molecular Medicine ·Valeria Chichagova, Μαρία Γεωργίου, Madeleine Carter, Birthe Dorgau, Gerrit Hilgen, Joseph Collin, Rachel Queen, Git Chung, Jila Ajeian, Marina Moya Molina, Stefan Kustermann, Francois Pognan, Philip Hewitt, Michael Schmitt, Evelyne Sernagor, Lyle Armstrong, Majlinda Lako	2023	21
6	Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation Transplantation and Cellular Therapy ·Lukas John, Sandra Sauer, Ute Hegenbart, Peter Dreger, Michael Hundemer, Carsten Müller‐Tidow, Anita Schmitt, Michael Schmitt, Marc S. Raab, Stefan Schönland	2023	4
7	HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma Biomedicines ·Wenjie Gong, Lei Wang, Maria‐Luisa Schubert, Christian Kleist, Brigitte Neuber, Sanmei Wang, Mingya Yang, Angela Hückelhoven‐Krauss, Depei Wu, Anita Schmitt, Carsten Müller‐Tidow, Hiroshi Shiku, Michael Schmitt, Leopold Sellner	2022	4
8	CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity Blood ·Tim Sauer, Kathan Parikh, Sandhya Sharma, Bilal Omer, David Sedloev, Qian Chen, Linus Angenendt, Christoph Schliemann, Michael Schmitt, Carsten Müller‐Tidow, Stephen Gottschalk, Cliona M. Rooney	2021	142
9	Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells Cells ·Wenjie Gong, Lei Wang, Sophia Stock, Ming Ni, Maria‐Luisa Schubert, Brigitte Neuber, Christian Kleist, Angela Hückelhoven‐Krauss, Depei Wu, Carsten Müller‐Tidow, Anita Schmitt, Hiroshi Shiku, Michael Schmitt, Leopold Sellner	2021	4
10	Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma PLoS Pathogens ·Jan Clement Santiago, Jason D. Goldman, Hong Zhao, Alec Pankow, Fred Okuku, Michael Schmitt, Lennie H. Chen, Catherine A. Hill, Corey Casper, Warren Phipps, James I. Mullins	2021	14
11	B‐cell maturation antigen‐specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives International Journal of Cancer ·Leopold Sellner, Fuli Fan, Nicola Giesen, Maria‐Luisa Schubert, Hartmut Goldschmidt, Carsten Müller‐Tidow, Peter Dreger, Marc S. Raab, Michael Schmitt	2020	9
12	Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR Cancers ·Maria‐Luisa Schubert, Alexander Kunz, Anita Schmitt, Brigitte Neuber, Lei Wang, Angela Hückelhoven‐Krauss, Sascha Langner, Birgit Michels, Antje Wick, Volker Daniel, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt	2020	14
13	Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies International Journal of Molecular Sciences ·Keun-Young Yoo, Yibin Liu, Lei Wang, Maria‐Luisa Schubert, Jean‐Marc Hoffmann, Sanmei Wang, Brigitte Neuber, Angela Hückelhoven‐Krauss, Ulrike Gern, Anita Schmitt, Carsten Müller‐Tidow, Peter Dreger, Andriy Mokhir, Michael Schmitt, Leopold Sellner	2019	15
14	Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells Cytotherapy ·Lei Wang, Wenjie Gong, Sanmei Wang, Brigitte Neuber, Leopold Sellner, Maria‐Luisa Schubert, Angela Hückelhoven‐Krauss, Alexander Kunz, Ulrike Gern, Birgit Michels, Mandy Hinkelbein, STEFANIE MECHLER, Petra Richter, Carsten Müller‐Tidow, Michael Schmitt, Anita Schmitt	2019	17
15	Donor lymphocyte infusion leads to diversity of specific T cell responses and reduces regulatory T cell frequency in clinical responders International Journal of Cancer ·Susanne Hofmann, Michael Schmitt, Marlies Götz, Hartmut Döhner, Markus Wiesneth, Donald Bunjes, Jochen Greiner	2018	10
16	Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-Immunotherapy EBioMedicine ·Georg Gdynia, Tadeusz Robak, Jürgen Kopitz, Anette Heller, Svetlana P. Grekova, Katarina Duglova, Gloria Laukemper, Monika Heinzel‐Gutenbrunner, Cornelius Gutenbrunner, Wilfried Roth, Anthony D. Ho, Peter Schirmacher, Michael Schmitt, Peter Dreger, Leopold Sellner	2018	4
17	Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma Transfusion ·Jian Cheng, Michael Schmitt, Patrick Wuchter, Eike C. Buss, Mathias Witzens‐Harig, Kai Neben, Michael Hundemer, Jens Hillengaß, Renate Alexi, Hartmut Goldschmidt, Bao‐an Chen, Anthony D. Ho, Anita Schmitt	2014	33
18	PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17) Clinical Cancer Research ·Lars Bullinger, Richard F. Schlenk, Marlies Götz, Ursula Botzenhardt, Susanne Hofmann, Annika C. Russ, Anna Babiak, Lu Zhang, Vanessa Schneider, Konstanze Döhner, Michael Schmitt, Hartmut Döhner, Jochen Greiner	2013	31
19	Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL). SHILAP Revista de lepidopterología ·Michael Schmitt, Agnieszka Bojarska−Junak, Anna Dmoszyńska, Krzysztof Giannopoulos, Jacek Roliński	2009	2
20	Presentation of a major histocompatibility complex class 1–binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide–truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy Blood ·Yasushi Ikuta, Naoyuki Katayama, Lijie Wang, Toshiharu Okugawa, Yoshiyuki Takahashi, Michael Schmitt, Gu Xiaogang, Masato Watanabe, Kazunari Akiyoshi, Hideo Nakamura, Kagemasa Kuribayashi, Junzo Sunamoto, Hiroshi Shiku	2002	84

About Michael Schmitt

Michael Schmitt is a scholar working on Immunology, Hematology, Oncology, Genetics and Transplantation, having authored 273 papers that have together received 7.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (99 papers), Immunotherapy and Immune Responses (73 papers), Immune Cell Function and Interaction (46 papers), Hematopoietic Stem Cell Transplantation (30 papers), Chronic Lymphocytic Leukemia Research (28 papers), Virus-based gene therapy research (28 papers), T-cell and B-cell Immunology (22 papers) and RNA Interference and Gene Delivery (21 papers). The work is most often cited by research in Immunology (2.6k citations), Oncology (3.2k citations), Hematology (1.3k citations), Genetics (683 citations) and Molecular Biology (2.6k citations). Michael Schmitt has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Anita Schmitt, Jochen Greiner, Lawrence A. Loeb, Hartmut Döhner, Carsten Müller‐Tidow, Maria‐Luisa Schubert, Peter Dreger, Jesse J. Salk, Mark Ringhoffer and Krzysztof Giannopoulos. Their work appears in journals such as Blood, International Journal of Cancer, International Journal of Oncology, Frontiers in Immunology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact